Immunovia AB Stock
Stocks
IMMNOV
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
19:00:00 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1506 SEK | -1.44% |
|
-2.21% | -33.66% |
| 08-18 | Seven stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 08-13 | Immunovia: Strong demand for blood test for pancreatic cancer, survey shows | FW |
| Market Cap | 101M 10.7M 9.17M 8.59M 7.84M 14.81M 1.02B 14.95M 39.44M 514M 40.16M 39.29M 1.7B | P/E 2026 * |
-1.51x | P/E 2027 * | -3.77x |
|---|---|---|---|---|---|
| Enterprise Value | 66.3M 7M 6M 5.62M 5.13M 9.69M 667M 9.79M 25.81M 337M 26.29M 25.71M 1.12B | EV / Sales 2026 * |
20.7x | EV / Sales 2027 * | 4.12x |
| Free-Float |
90.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -1.44% | ||
| 1 week | -2.21% | ||
| Current month | -16.15% | ||
| 1 month | -13.94% | ||
| 3 months | -28.11% | ||
| 6 months | -18.06% | ||
| Current year | -33.66% |
| 1 week | 0.14 |  | 0.16 |
| 1 month | 0.14 | | 0.19 |
| Current year | 0.14 | | 0.25 |
| 1 year | 0.14 | | 0.96 |
| 3 years | 0.14 | | 4.73 |
| 5 years | 0.14 | | 141.5 |
| 10 years | 0.14 | | 298.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 29/04/2023 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/04/2024 |
| Chief Tech/Sci/R&D Officer | 54 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 09/12/2016 | |
Peter Andersen
CHM | Chairman | 69 | 26/05/2023 |
| Director/Board Member | 51 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/15/22 A | Buy | Chief Executive Officer | 150,000 | 0.6628% | ||
| 5/24/22 A | Buy | Chief Executive Officer | 100,000 | 0.4419% | ||
| 5/21/22 A | Buy | Chief Executive Officer | 100,000 | 0.4419% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.44% | -2.21% | -81.59% | -85.29% | 10.83M | |
| +1.40% | +7.69% | +27.16% | -28.88% | 17.58B | |
| +15.78% | +0.07% | -30.47% | +110.64% | 1.49B | |
| +3.86% | +12.06% | -45.57% | -80.48% | 994M | |
| 0.00% | -1.13% | -24.56% | +23.87% | 962M | |
| -0.11% | +0.22% | +62.28% | -5.56% | 781M | |
| +2.67% | +1.05% | -38.28% | -44.75% | 671M | |
| +3.43% | -8.53% | -44.27% | -48.79% | 544M | |
| -0.54% | +2.50% | -39.43% | -33.78% | 461M | |
| +0.73% | +9.13% | +75.44% | +52.57% | 451M | |
| Average | +2.58% | +3.49% | -13.93% | -14.05% | 2.39B | |
| Weighted average by Cap. | +2.32% | +6.78% | +15.74% | -18.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 338K 290K 271K 248K 468K 32.21M 472K 1.25M 16.25M 1.27M 1.24M 53.82M | 17.3M 1.83M 1.57M 1.47M 1.34M 2.53M 174M 2.55M 6.73M 87.86M 6.86M 6.71M 291M |
| Net income | -87M -9.19M -7.87M -7.38M -6.74M -12.71M -876M -12.84M -33.87M -442M -34.49M -33.74M -1.46B | -76M -8.02M -6.88M -6.44M -5.89M -11.11M -765M -11.22M -29.59M -386M -30.13M -29.47M -1.28B |
| Net Debt | -35M -3.7M -3.17M -2.97M -2.71M -5.12M -352M -5.17M -13.63M -178M -13.88M -13.57M -589M | -30M -3.17M -2.71M -2.54M -2.32M -4.38M -302M -4.43M -11.68M -152M -11.89M -11.63M -505M |
Employees
18
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | SEK 0.1506 | -1.44% | 3,728,896 |
| 24/08/26 | SEK 0.1528 | +0.39% | 4,958,717 |
| 21/08/26 | SEK 0.1522 | -3.67% | 2,623,989 |
| 20/08/26 | SEK 0.1580 | +0.38% | 1,687,733 |
| 19/08/26 | SEK 0.1574 | +2.21% | 1,347,285 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
Select your edition
All financial news and data tailored to specific country editions
